Study Examining the PROMUS Element Everolimus-eluting Stent in Multi-center Coronary Intervention of Complex Arterial Lesion Subsets

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 800 participants.

Also called NCT01670318

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 800 participants (planned count) (from the registry)
Sponsor
The PCI Guideline Research Society (from the registry)
Registry
  • NCT NCT01670318
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Japan (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01670318. Non-randomized; no masking; primary purpose treatment. Start 2012-08 (registry gives no type); primary completion 2013-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study Examining the PROMUS Element Everolimus-eluting Stent in Multi-center Coronary Intervention of Complex Arterial Lesion Subsets
Acronym
SPECIALIST
Intervention (Device)
platinum chromium everolimus-eluting stent (PROMUS Element by Boston Scientific, Massachusetts)
Lead sponsor
The PCI Guideline Research Society (class: research network)

Record details

Record id
cardio:ct-nct01670318
Content hash
d458d3822cf26bcf07a6f2ff613ad48acc138ad79275aa30a9a5f55a6aaf0037